InvestorsHub Logo

pizzler1218

10/08/18 7:58 PM

#30057 RE: CMohnR #30056

Biotech_Tradez Inc.

Crozz

10/09/18 1:27 PM

#30058 RE: CMohnR #30056

It could be any of the large Pharma companies or even Medical Device companies. I believe, if GSK starts gaining traction with their electroceuticals, then their competitors may want to quickly slip into this space and Endonovo would likely be the company with products best positioned to compete and would be easily obtained for pocket change. That may already be happening and if so, a Pfizer, Merck, Lilly, or any number of medium sized Pharma companies could easily purchase ENDV for very little at this point. For arguments sake, if a company believed strongly in electroceuticals and wanted to get in early and cheap, this is the company for them. We all agree that the technology here is great...management isn't, so maybe this is primed for a buyout.

If it were a medical device company to purchase, which I don't think would happen this early, I would say that this could fit well into Medtronic or Boston Scientific's portfolio of electronic devices. Just my humble opinions.

Craig305

10/10/18 8:46 AM

#30059 RE: CMohnR #30056

I can't make an educated speculation on who might be interested in ENDV.

I can only say with certainty it won't be GSK. They are committed to the implantable Electroceuticals.